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HMGN1 Modulates Nucleosome Occupancy and DNase I
Hypersensitivity at the CpG Island Promoters of Embryonic Stem
Cells
Tao Deng,a Z. Iris Zhu,b Shaofei Zhang,a Fenfei Leng,a,c Srujana Cherukuri,a Loren Hansen,b* Leonardo Mariño-Ramírez,b
Eran Meshorer,d David Landsman,b Michael Bustina
Protein Section, Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USAa; Computational Biology Branch, National
Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, Maryland, USAb; Department of Chemistry & Biochemistry,
Florida International University, Miami, Florida, USAc; Department of Genetics, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem,
Jerusalem, Israeld

Chromatin structure plays a key role in regulating gene expression and embryonic differentiation; however, the factors that determine the organization of chromatin around regulatory sites are not fully known. Here we show that HMGN1, a nucleosomebinding protein ubiquitously expressed in vertebrate cells, preferentially binds to CpG island-containing promoters and affects
the organization of nucleosomes, DNase I hypersensitivity, and the transcriptional profile of mouse embryonic stem cells and
neural progenitors. Loss of HMGN1 alters the organization of an unstable nucleosome at transcription start sites, reduces the
number of DNase I-hypersensitive sites genome wide, and decreases the number of nestin-positive neural progenitors in the
subventricular zone (SVZ) region of mouse brain. Thus, architectural chromatin-binding proteins affect the transcription profile and chromatin structure during embryonic stem cell differentiation.

E

mbryonic stem cell (ESC) pluripotency and differentiation
are controlled by the coordinated action of multiple epigenetic factors that affect the structure of chromatin and regulate
gene expression. These include transcription factors, chromatin remodeling complexes, and additional proteins that alter
the properties of chromatin such as linker histone H1 variants
and members of the high-mobility-group (HMG) protein superfamily (1–5).
Histone H1 variants and HMG protein are ubiquitously found
in the nuclei of all vertebrate cells. These structural proteins bind
dynamically to nucleosomes without any known DNA sequence
specificity (6, 7), modulate the local and global structures of chromatin, and affect gene expression. Histone H1 represents the most
abundant family of chromatin-binding proteins; most nuclei contain sufficient H1 molecules to bind to all the nucleosomes. The
interaction of H1 with nucleosomes stabilizes the compact, higher-order chromatin structure (8). Vertebrate nuclei contain 3
families of HMG proteins, named HMGA, HMGB, and HMGN,
each of which induces specific alterations in DNA or chromatin
structure (9, 10).The dynamic binding of HMGs to nucleosomes
reduces the interaction of H1 with chromatin and can counteract
the chromatin-condensing activity of H1 (7, 11). Thus, the interplay between H1 and HMG proteins could play a role in chromatin dynamics and function (12). Although extensively studied, the
cellular function and mechanism of action of these chromatin
architectural proteins, and the extent to which they can affect the
properties of ESCs, are not fully elucidated.
Here we examine the role of HMGN1, a major variant of the
HMGN protein family, in regulating the chromatin structure and
properties of mouse embryonic stem cells (ESCs) during their
differentiation along the neuronal pathway. HMGNs could affect
chromatin structure and ESC differentiation because they bind
specifically to nucleosome core particles (CPs) (13, 14), affect the
levels of histone modifications (15), and have been linked to the
generation of DNase I-hypersensitive sites (DHS) (16), the hall-
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mark of chromatin regulatory sites. HMGNs counteract the activity of certain nucleosome remodeling complexes (17) and thus
could affect nucleosome positioning (18, 19). In human T cells,
HMGN1 preferentially localizes to chromatin regulatory regions
such as promoters, enhancers, and nucleosomes bordering CTCF
sites (20); in tissue culture cells, either up- or downregulation of
HMGN1 levels alters the cellular transcription profile (21). Furthermore, the expression of HMGN genes is related to differentiation processes such as erythropoiesis, myogenesis, osteoblast
differentiation, kidney organogenesis, preimplantation development of early mouse embryo, and Xenopus embryogenesis (22).
Transient depletion of HMGN proteins from one- or two-cell
mouse embryos slowed the progression of preimplantation development (23), and altered HMGN expression during Xenopus embryogenesis led to malformed tadpole embryos (24). Taken together, these results suggest a link between regulated expression of
HMGN proteins and cellular differentiation.
To test whether HMGN1 could affect ESC differentiation in
the biological context of a whole organism, we first verified that
the protein is expressed during preimplantation development
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(23). We found robust HMGN1 expression throughout all these
developmental stages and therefore generated ESCs from
Hmgn1⫺/⫺ mice, induced them to differentiate along the neuronal
pathway, and compared their chromatin structure and transcription profiles to those of Hmgn1⫹/⫹ ESCs. We found strong preferential binding of HMGN1 to promoters containing CpG islands
(CGI), especially when these were transcriptionally active. Significantly, using limiting micrococcal nuclease digests, we detected
an unstable nucleosome positioned at the transcription start sites
(TSS) of CGI promoters, in a region considered to be “nucleosome depleted” (25–27). The stability of these nucleosomes is related to transcription and affected by HMGN1. Likewise, we
found that HMGN1 colocalizes with and affects the hypersensitivity of DHS at the CGI promoters of ESCs. Loss of functional
HMGN1 did not noticeably affect ESC differentiation but led to
changes in the cellular transcription profiles of neural progenitor
cells (NPCs) and neurons. In mouse brain, loss of HMGN1 led to
a decrease of nestin-positive NP cells in the subventricular stem
cell zone.
Our report provides additional information on the chromatin
landscape of ESCs and NPCs and identifies HMGN1 as a protein
that affects chromatin structure at the transcription start sites of
promoters containing CpG islands of ESCs and that modulates the
number of nestin-positive cells in mouse brain.
MATERIALS AND METHODS
ES cell culture and in vitro differentiation. Hmgn1⫹/⫹ and Hmgn1⫺/⫺
ESC lines were derived from littermate 3.5-day blastocytes obtained from
Hmgn1⫹/⫺ and Hmgn1⫹/⫺ mice matings (28). In Hmgn1⫺/⫺ cells, we
deleted exons II to IV, which code for the nucleosome-binding domain of
the protein (29). The ES cells were cocultured with mitomycin C-treated
primary mouse embryonic fibroblast (MEF) feeders (Millipore) or cultured under feeder-free conditions; they were maintained in Knockout
Dulbecco’s modified Eagle’s medium (KO-DMEM; Invitrogen), with
20% serum replacement (SR; Invitrogen), 0.055 mM ␤-mercaptoethanol
(Sigma), 2 mM L-glutamine (Invitrogen), 0.1 mM MEM nonessential
amino acid (Invitrogen), 5,000 U/ml penicillin-streptomycin (Invitrogen), and 1,000 U/ml leukemia inhibitory factor (LIF) (Millipore). Cells
were passaged every 2 days using 0.05% trypsin–EDTA. In vitro differentiation of ES cells according to neural lineage was performed using a
mouse dopaminergic neuron differentiation kit (R&D Systems) according to the manufacturer’s instruction.
RNA and cDNA preparation. Equal amounts of cells were used for
total RNA isolation by the use of an RNeasy Mini kit (Qiagen) followed by
“on-column” DNase I treatment. RNA (500 ng) was used for cDNA synthesis by iScript kit (Bio-Rad). Equal amounts of cDNA were applied for
real-time PCRs with Power SYBR green mix (Applied Biosystems). ␤-Actin served as an internal control. Reactions and measurements were performed using an AB 7900HT Fast real-time PCR system and software.
Antibodies, Western blotting, and immunostaining. Rabbit affinity
pure polyclonal anti-mouse HMGN1 antibodies were generated in our
laboratory (29). Antiactin antibody was from Sigma (A5316). AntiOct3/4 antibody was from Santa Cruz (sc-5279), antinestin antibody was
from Millipore (MAB-353), and anti-tyrosine hydroxylase (anti-Th) antibody was from Tel-Freez (P40101). Horseradish peroxidase (HRP)-conjugated secondary antibodies for Western blots were from Pierce. Fluorescence secondary antibodies were Alexa Fluor 488 – donkey anti-rabbit
IgG and Alexa Fluor 568 – donkey anti-mouse IgG (Invitrogen). For
Western blots, whole-cell lysates were prepared in 1⫻ SDS-PAGE sample
buffer (Bio-Rad) supplemented with protease inhibitors (Roche Applied
Science). The samples were fractionated on 15% precast Criterion gels,
transferred by the semidry method to a polyvinylidene difluoride (PVDF)
membrane, blocked with nonfat milk in Tris-buffered saline–Tween 20
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(TBST), and probed with antibodies. Chemiluminiscent detection using
ECL Plus has been performed according to Amersham recommendations.
For immunostaining, ES cells, neural progenitors, and neurons were
grown on coverslips under the conditions described above. Frozen brain
sections (30 m thick) were prepared from 2-week-old Hmgn1⫹/⫹ and
Hmgn1⫺/⫺ mice. Immunofluorescence staining was performed using the
corresponding antibodies showed in the figures as previously described
(30). The images from cultured cells were taken using a Nikon Eclipse
E800 fluorescence microscope and processed using NIS-Elements software (Nikon). The images from the brain sections were taken using a Zeiss
LSM 710 confocal system and were processed using Zeiss software.
Dissection of mouse SVZ region. The whole brains of 2-week-old
male Hmgn1⫹/⫹ and Hmgn1⫺/⫺ mice were collected. Sections (1 mm
thick) were cut using a mouse brain mold and snap-frozen on glass slides
on dry ice. The subventricular zone (SVZ) regions from all corresponding
sections were dissected using no. 5 tweezers (Dumont) under a dissection
microscope and pooled.
Transcription profiling. Microarray expression analysis of total RNA
from ES cells, neural progenitors, and neurons was performed using Affymetrix Mouse GeneChips 430 2 (430V2) as described previously (21).
Three replicates of Hmgn1⫹/⫹ and Hmgn1 ⫺/⫺ ESCs, NPCs, and neurons
were generated. All analysis was performed using R and BioConductor
(31). The quality of the arrays were evaluated with R package version
1.18.0 “affy” (32) and “simpleaffy” (33). Expression levels were derived
using the Robust Multichip Average (RMA) protocol (34) with default
settings. Differentially expressed genes were identified using an empirical
Bayes method implemented in the R package “Limma” (34). P values were
corrected for multiple testing using a false-discovery-rate method. Genes
that have a ⱍlog2 (fold change)ⱍ value ⱖ 1 and for which the adjusted P
value is ⱕ0.01 are considered differentially expressed between two conditions (i.e., between Hmgn1⫹/⫹ and Hmgn1⫺/⫺) or between two differentiation states (i.e., NP versus ES or neuron versus NP).
ChIP-Seq. About 2 ⫻ 107 cells (feeder-free ES cells or neural progenitors) were cross-linked directly in culture medium with 1% formaldehyde solution for 10 min at room temperature. Chromatin was fragmented to 200 to 500 bp by sonication (Bioruptor). Chromatin
immunoprecipitation (ChIP) experiments were performed using Dynabeads (Invitrogen) and affinity-purified anti-HMGN1. For preparation of
sequencing libraries, 20 ng ChIP DNA or input DNA (samples reserved
before ChIP) were end repaired using an End-It DNA end repair kit (Epicentre), and then an “A” was added to the 3= end using Klenow (3=–5=
exo-) (NEB). After ligation with Illumina adaptors, 200-to-300-bp DNA
fractions were size selected on a 2% E-gel (Invitrogen), extracted, and then
amplified by 18 cycles of PCR using Illumina primers and Phusion DNA
polymerase (NEB). Libraries were purified by the use of Agencourt Ampure beads (Beckman Coulter) and then sequenced on Illumina Genome
Analyzer IIx with 36-bp single-end reads.
DNase I hypersensitivity assays. For genome-wide analysis, intact
nuclei were isolated from trypsinized cells by incubation on ice for 10 min
in buffer containing 0.02% IGEPAL CA-630 (Sigma), 1 mM EDTA, 0.5
mM EGTA, 0.5 mM spermidine, and protease inhibitor (Roche Applied
Science). DNase I digestion was carried out by incubation of 2 ⫻ 107
nuclei with 40 U/ml DNase I (Roche Applied Science) at 37°C for 3 min.
After treatment by RNase A and proteinase K, DNA was recovered by
phenol-chloroform extraction. DNA fragments with sizes between 150
and 500 bp were isolated by 9% sucrose gradient centrifugation. Construction of libraries and sequencing were performed the same way as
described above for the ChIP-Seq samples. DNase I accessibility assays
were performed to validate the genome-wide analysis. DNase I digestions
were done using 40, 60, or 80 U/ml DNase I. The digested DNA was
precipitated, and equal amounts of DNA were analyzed by quantitative
real-time PCR as described previously. Primers are available upon request.
Genome-wide nucleosome-positioning assay. Mononucleosomal
DNAs from wild-type and Hmgn1⫺/⫺ ES cells and neural progenitors
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were isolated by micrococcal nuclease digestion using an EZ Nucleosomal
DNA Prep kit (Zymo Research) according to the manufacturer’s instruction. In brief, nuclei were isolated from trypsinized cells by incubation on
ice for 5 min in Nuclei Prep buffer. Nuclei (1.5 ⫻ 106) were then digested
using 0.05 to 0.5 unit of micrococcal nuclease in 100 l MN Digestion
buffer at room temperature for 10 min. Nucleosomal DNA was purified
using the columns supplied with the kit and then was then processed on
2% agarose gel to check the size. Mononucleosomal DNA was selected for
construction of Illumina sequencing libraries. Library preparation and
sequencing were performed as described above for ChIP-Seq.
Bioinformatic ChIP-Seq, DNase I-Seq, and MNase-Seq analyses.
The Mouse Genome 430 2.0 array has 45,101 probe sets associated with
19,824 Mouse Genome Informatics (MGI) gene identifiers. Of these,
17,392 are experimentally validated and are listed in the NCBI RefSeq
“NM” gene database. We used these coordinates for TSS analysis. Probe
sets were mapped to MGI identifiers using information provided by the
Jackson Laboratory (http://www.informatics.jax.org/). Unfiltered sequencing reads (from ChIP-Seq, DNase I-Seq, or MNase-Seq) were
aligned to the mouse reference genome (NCBI build 37, mm9) using
Bowtie (35). Up to 1 mismatch was allowed for each aligned read. Only
uniquely aligned reads were collected for further analysis. Binding regions
were identified using SICER (36) with the following parameters: effective
genome size, 0.787 (78.7% of the mouse genome is mappable); window
size, 100 bp for HMGN ChIP-Seq and 50 bp for DNase I-Seq; gap size, 100
bp for HMGN ChIP-Seq and 50 bp for DNase I-Seq. The SICER score
in the graph can be viewed as an indication of peak intensity. Calculation of coverage and identification of overlapping binding regions
were performed with the “chipseq” and “GenomicRanges” packages in
BioConductor (31). Specifically, in analyzing MNase-seq data, since the
reads are from the ends of the mononucleosome particle, to best visualize
the nucleosome positions, all the reads were shifted to the middle of the
corresponding nucleosome core. The average sizes of mononucleosome
fragments purified from a 2% agarose gel were determined by Bioanalyzer
(Agilent). For normalization, the calculation of coverage at any regions
and the comparisons between different data sets were preceded by library
size normalization. Control subtraction was carried out in the following
way: coverage (exp)/N1 ⫺ coverage (control)/N2, in which “exp” is the
data set (in .bam format) to be examined, N1 is the library size of the
experimental data (“exp”), and N2 is the library size of the control. In this
study, input sequences (DNA sequences after sonication only without
immunoprecipitation) were used as a control. The function coverage that
calculates genome coverage from .bam files is from the “chipseq” package
in BioConductor (31).
Microarray data accession numbers. The results of the analysis of the
transcription changes during differentiation have been deposited at the
Gene Expression Omnibus (GEO) database under accession no.
GSE44175. We have deposited the BAM files in the SRA database (accession number SRA066756).

RESULTS

Differentiation of Hmgn1ⴚ/ⴚ embryonic stem cells along the
neural lineage. To test whether HMGN1 could affect ESC differentiation, we first reexamined the HMGN1 expression pattern
during mouse early embryonic differentiation (23). We found robust HMGN1 expression in oocytes and throughout all preimplantation stages, including the blastocyst stage (Fig. 1A), raising
the possibility that HMGN1 affects the chromatin structure and
differentiation potential of ESCs. We therefore established ESCs
from Hmgn1⫹/⫹ and Hmgn1⫺/⫺ mice. Western blots (Fig. 1C)
and immunofluorescence (Fig. 1D) verified that the Hmgn1⫺/⫺
ESCs lacked intact HMGN1 protein. Loss of HMGN1 did not
affect the viability or morphology of the ESCs. The Hmgn1⫺/⫺
ESC colonies, just like the Hmgn1⫹/⫹ colonies, remained undifferentiated, as indicated by staining for alkaline phosphatase
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(Fig. 1E), immunostaining for Oct3/4 (Fig. 1D), and reverse transcription-PCR (RT-PCR) analysis of Nanog levels (Fig. 1H).
To test whether loss of HMGN1 affects the differentiation potential of the ESCs, we induced differentiation along the neuronal
pathway (Fig. 1B). Upon removal of LIF, both the Hmgn1⫺/⫺ and
Hmgn1⫹/⫹ ESCs formed embryoid bodies which could be further
induced to differentiate into nestin-expressing NPCs as indicated
by immunofluorescence and quantitative RT-PCR (Fig. 1F and
H). Further differentiation toward dopaminergic neurons resulted in cultures in which most cells developed axons and dendrites, a morphology characteristic of adult neurons (Fig. 1B; see
also Fig. S1 in the supplemental material). Immunostaining for
tyrosine hydroxylase (TH) revealed that about half of the neurons
were dopaminergic neurons (Fig. 1G). The mRNA expression patterns of Nanog, Nestin, and tropomyosin-related kinase B (TrkB),
which serve as differentiation markers for ESCs, NPCs, and adult
neurons, respectively, further confirmed that the Hmgn1⫺/⫺ ESCs
differentiated properly along the neuronal pathway (Fig. 1H).
HMGN1 depletion affects gene expression during ES cell differentiation. Alterations in HMGN levels can affect gene expression, leading to phenotypes that are not immediately obvious (22,
29, 37–39). Therefore, we compared the transcription profiles of
Hmgn1⫹/⫹ ESCs, NPCs, and neurons to those of Hmgn1⫺/⫺ cells
at the same three differentiation stages. Loss of HMGN1 altered
significantly the expression of 19, 169, and 85 genes in ESCs,
NPCs, and neurons, respectively (Fig. 2A and B; see also Table S1A
in the supplemental material). Quantitative RT-PCR (Q-PCR)
analysis of 9 upregulated and 9 downregulated genes (the 3 that
were most changed, 3 that were moderately changed, and the 3
that were least changed) at each differentiation stage verified the
microarray results (see Table S2 in the supplemental material).
Gene ontology analysis performed using DAVID (40) for all the
genes with altered expression revealed that genes involved in developmental processes, especially in organ morphogenesis, vasculature development, and tissue development, were the genes most
severely affected (see Table S3 in the supplemental material).
Progression through the differentiation stages leading from
ESCs to neurons involves major changes in the expression of numerous genes. In both Hmgn1⫹/⫹ and Hmgn1⫺/⫺ cells, close to
4,000 genes showed expression level changes during the switch
either from ESCs to NPCs or from NPCs to neurons. Over 85% of
these changes involved the same genes in both Hmgn1⫹/⫹and
Hmgn1⫺/⫺ cells. In Table S1B and C in the supplemental material,
we list the gene names and their fold change values in both
Hmgn1⫹/⫹ or Hmgn1⫺/⫺ cells. In the experiment represented by
Fig. 2C, we first sorted the genes based on their fold changes in
expression levels in Hmgn1⫹/⫹ cells and then plotted these sorted
genes versus the corresponding fold changes in both Hmgn1⫹/⫹
(blue) and Hmgn1⫺/⫺ (red) cells. The differences between red
crosses and blue dots indicate that the magnitude of the differentiation-related changes in gene expression was affected by loss of
HMGN1 (Fig. 2C). These changes are not due to variations between microarray replicates, because each point represents the
fold change calculated from 3 replicates from each cell type,
whereas separate control analyses of all the possible versions of the
2 replicates revealed that the variations within the Hmgn1⫺/⫺
or Hmgn1⫹/⫹ groups were very small (see Fig. S2 in the supplemental material). The mean variation between Hmgn1⫹/⫹
and Hmgn1⫺/⫺ cells was more than 4-fold bigger than the variation within duplicates (0.327 versus 0.067 [P value ⬍ 2.2e–16;
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FIG 1 Effects of Hmgn1 depletion on in vitro ES cell differentiation. (A) HMGN1 protein expression during mouse embryonic preimplantation. Immunofluorescence images at the stages indicated above each panel are shown. (B) Morphology of Hmgn1⫹/⫹ and Hmgn1⫺/⫺ ES cell colonies during differentiation along
the neuronal pathway. (C) Genotyping (29) and Western analysis of the ES cells used. (D) Immunofluorescence of Oct3/4, an ES cell marker, in the ES cell
colonies. (E) Both Hmgn1⫹/⫹ and Hmgn1⫺/⫺ ES cell colonies express the pluripotency marker alkaline phosphatase. (F) Immunofluorescence of the neural
progenitor nestin. (G) Immunofluorescence of the dopaminergic neuron marker tyrosine hydroxylase (Th). (H) Quantitiative RT-PCR analysis of the expression
of Hmgn1, Nanog, Nestin, and tropomyosin-related kinase B (TrkB) during Hmgn1⫹/⫹ and Hmgn1⫺/⫺ ES cell neural differentiation. The values obtained in ES
cells were set to 100%.

Wilcoxon rank sum test]). Thus, HMGN1 modulates and fine
tunes the general fidelity of the cellular transcription profile and
does not serve as a specific transcription factor that regulates the
expression of a select subset of genes.
Reduced nestin-positive cells in the SVZ of Hmgn1ⴚ/ⴚ mice.
The Allen Brain Atlas database reveals prominent Hmgn1 expression in the SVZ, in the hippocampus, and in the olfactory bulbs
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(Fig. 3A), three regions enriched in neural stem/progenitor cells
and active in neurogenesis. Indeed, immunofluorescence staining
of brain sections from a 2-week-old mouse indicated that
HMGN1 protein was most prominently expressed in the SVZ and
the hippocampus, where the cells are tightly packed, as indicated
by Hoechst staining (Fig. 3B). Double immunofluorescence analysis of the SVZ regions revealed that nuclei of nestin-expressing

Molecular and Cellular Biology

HMGN1 Affects ESC Chromatin

FIG 2 HMGN1 depletion affects gene expression during ES cell differentiation along the neuronal pathway. (A) Transcription analysis of Hmgn1⫹/⫹ and

Hmgn1⫺/⫺ cells in the ES, NP, and neuron stages. Red dots mark genes (listed in Table S1A in the supplemental material) that were significantly affected by loss
of HMGN1. (B) Clustering of genes (represented in panel A) across three differentiation states based on expression values. (C) Comparison of fold changes in
gene expression during differentiation processes from ESCs to NPCs or NPCs to neurons in Hmgn1⫹/⫹ and Hmgn1⫺/⫺ cells. The difference between red and blue
visualizes the effects of HMGN1 loss on gene expression during differentiation.

cells contained significant amounts of HMGN1, an indication that
HMGN1 was expressed in mouse NPCs (Fig. 3C).
To test whether loss of HMGN1 affects NPC characteristics in
the biological context of the entire organism, we compared the
levels of nestin-positive cells in Hmgn1⫺/⫺ and Hmgn1⫹/⫹ littermates. Immunofluorescence analysis indicated that loss of
HMGN1 reduced the number of nestin-positive cells in the SVZ
region (Fig. 3D), and quantitative RT-PCR analysis of RNA isolated from the SVZ regions verified that the expression of Nestin
mRNA in the Hmgn1⫺/⫺ SVZ was reduced by 40% compared to
that seen in the Hmgn1⫹/⫹ SVZ (Fig. 3E). Thus, loss of HMGN1
reduces the number of nestin-positive cells in the SVZ region of
mouse brain.
HMGN1 preferentially binds to promoters containing CpG
islands. To gain insights into the mechanisms whereby HMGN1
affects transcriptional fidelity, we examined the genome-wide distribution of HMGN1 in ESCs and NPCs. Chromatin immunoprecipitation sequencing (ChIP-Seq) failed to yield reliable data on
the localization of HMGN1 in ESCs, most likely because their
chromatin is hyperdynamic (41, 42) and the chromatin residence
time of many nuclear proteins, including HMGN1 (see Fig. S3 in
the supplemental material), is relatively short. In NPCs, however,
we were able to determine the genome-wide distribution of
HMGN1.
In NPCs, 72% of the HMGN1-binding regions were located
at gene promoter regions and within gene bodies (Fig. 4A). The
HMGN1 peaks in the promoter regions were significantly more
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intense (P value ⬍ 2.2e–16; Wilcoxon rank sum test), an indication of preferential association with these regions (Fig. 4B).
Significantly, we found a striking overlap between HMGN1binding promoters and CGI-containing promoters. Among all
24,303 annotated promoters in the NCBI Mouse mm9 Refseq
database (http://hgdownload.soe.ucsc.edu/goldenPath/mm9
/database/), there are 15,112 CGI promoters, 10,892 (72%) of
which are bound by HMGN1. Conversely, 10,892 (92%) of all
11,881 promoters bound by HMGN1 also contain CGI. In contrast, among the 9,181 non-CGI promoters, only 989 (11%)
bind HMGN1 (Fig. 4C).
The Mouse genome transcription arrays contain 45,101 probes
which identify 17,392 experimentally validated genes annotated in
the Mouse Genome Informatics (MGI) database (43) and listed in
the NCBI Refseq database (44). The HMGN1 signal strength at the
promoters of the 6,956 most actively transcribed (40% of total
genes [Top40]) genes is significantly stronger than at those of the
40% least-transcribed genes (Bot40) (t test P value ⬍ 2.2e–16), an
indication that HMGN1 preferentially associates with transcriptionally active genes (see Fig. S4 in the supplemental material).
In the Top40 and Bot40 groups, 6,516 (94%) and 3,416 (46%)
genes, respectively, contain CGI in their promoters. As shown in
Fig. 4D, in the Top40 gene group, the average HMGN1 binding
level was 4-fold higher at CGI promoters (black) than at non-CGI
promoters (red) (t test P value ⬍ 2.2e–16). Furthermore, even in
the Bot40 group, the HMGN1 binding to CGI promoters (blue)
was 3-fold higher than to the non-CGI promoters (t test P value ⬍
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FIG 3 Decreased nestin-positive cells in the brain of Hmgn1⫺/⫺ mice. (A) High Hmgn1 expression in the subventricular zone (SVZ), hippocampus, and olfactory
bulbs of mouse brain (from www.brain-map.org with permission). The inset shows the corresponding Nissl image. (B) Immunofluorescence staining in
2-week-old Hmgn1⫹/⫹ brain reveals high HMGN protein levels in mouse hippocampus and SVZ (outlined by dashes). (C) Double immunofluorescence reveals
colocalization of nestin in the cytoplasm of cells expressing HMGN1 in the SVZ region. A magnified image of the area outlined by dashed lines is shown under
each panel. (D) Decreased nestin immunofluorescence staining in the SVZ (outlined) of 2-week-old Hmgn1⫺/⫺ mice. (E) Decreased Nestin expression in the SVZ
of Hmgn1⫺/⫺ mice detected by RT-PCR (*, P ⬍ 0.01).

2.2e–16). This distribution pattern was not related to transcription level since, in either the Top 40 or the Bot40 group, the gene
expression levels were not related to the CGI content in their promoters (Fig. 4D, inset). Thus, the major driving force of HMGN1
binding to promoters is the presence of CGI, rather than the gene
expression level. In agreement, HMGN1-binding sites colocalized
with H3K4Me3 (Fig. 4E and F), a histone mark associated with
transcription initiation at CGI promoters (45).
HMGN1 affects nucleosome organization at TSS of CpG
island-containing promoters in ESCs. The organization of
nucleosomes in promoters plays an important role in regulating
gene expression levels. Given that HMGN1 binds specifically to
nucleosomes (13, 14), we mapped the nucleosome organization in
Hmgn1⫹/⫹ and Hmgn1⫺/⫺ ESCs and NPCs by deep sequencing of
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mononucleosomal DNA isolated from micrococcal nuclease digests. In these digests, the most accessible nucleosomes are released first and then further digested, and the corresponding DNA
may not be included in the mononucleosomal fraction of an extensive digest. Therefore, we mapped the genome-wide positions
of nucleosomes present in either limited or extensive digests
when, respectively, either only ⬃5% or more than ⬃80% of the
chromatin was converted to mononucleosomes. In these experiments, we ensured that the wild-type and knockout cells were
digested to the same extent (Fig. 5A).
The nucleosome positions seen in extensive digestion of both
Hmgn1⫹/⫹ ESCs and NPCs were very similar to those seen in
other cells and revealed a region depleted of nucleosome at the
TSS and flanked by nucleosomes up- and downstream (Fig. 5B).
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FIG 4 Genome-wide distributions of HMGN1 in neural progenitor cells. (A) Global distribution of HMGN1 throughout the genome. (B) Enhanced HMGN1binding strength at promoters. (C) HMGN1 binds to promoters containing CpG islands. Note that 92% of the HMGN1-binding promoters are CpG island
promoters and that 70% of the CpG island promoters bind HMGN1, regardless of expression levels. (D) Average HMGN1 signals near the transcription start site
(TSS) of different groups of genes. Black line, Top40 genes with CpG island promoters; red line, Top40 genes with non-CpG island promoters; blue line, Bot40
genes with CpG island promoters; green line, Bot40 genes with non-CpG island promoters. RPM, reads per million. The inset indicates average expression values
(in log2) in the four groups of genes. (E) An example of colocalization of HMGN1, CpG island promoters, and H3K4Me3 histone mark. (F) Overlapping of
HMGN1-binding promoter and H3K4Me3-positive promoters.

The ⫹1 nucleosome is the best positioned, as manifested by the
highest peak at that site. However, analysis of the limited MNase
digestions clearly reveals the presence of a nucleosome positioned
at the TSS in the “nucleosome-free” regions seen in extensive digestions (arrows, Fig. 5B). The linker DNA regions flanking these
nucleosomes are likely the most accessible to the enzyme, and
therefore these nucleosomes are the first to be released from the
chromatin fiber. Since these nucleosomes may contain histone
variants that render them unstable (46), the corresponding DNA
fragment is rapidly digested by MNase, resulting in the “nucleosome-free valley” typically seen at the TSS in extensive MNase
digests.
In view of the extensive localization of HMGN1 at CGI promoters, we examined the nucleosome organization at both CGI
and non-CGI promoters in the Top40 and Bot40 gene groups. We
found that in both ESCs and NPCs, the nucleosomes in the TSS
regions containing CGI were significantly better positioned than
in non-CGI promoters in both extensive and limited digests (Fig.
5C and D). The nucleosome at the TSS (position 0) is clearly seen
in the limited digests but not in the extensive digests of CGI promoters of the Top40 group (Fig. 5D, arrow).
We separated the CGI promoter genes of ESC and NPC into 8
groups based on their expression values and mapped the nucleosome positions around the TSS in each group (Fig. 5E and F). In
the least-expressed group (T1; red line) the signal from the unstable nucleosome at TSS was highest in the extensive digestion but
lowest in the limited digestion. Conversely, the signal from the
most-expressed genes was highest in the limited digestions and
lowest in the extensive digestion (Fig. 5E and F), a finding that is
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fully compatible with the notion that the DNA signal at this
position is related to transcription level. The nucleosome at
position ⫹1 became more stable or better positioned as gene
expression levels increased. In summary, in TSS regions of the
promoters containing CGI, the stability of the nucleosomes is
related to transcription levels; enhanced transcription destabilizes the nucleosomes at the TSS (position 0) but stabilizes the
nucleosome at the ⫹1 site.
Loss of HMGN1 increased the peak height of all nucleosomes
(from ⫺3 to ⫹5) around the TSS of CGI promoters but only in
limited digests. The effects were not seen in extensive digests or at
non-CGI promoters (Fig. 5G and H). The increased peak height
may reflect changes in nucleosome occupancy or accessibility,
perhaps due to effects of HMGN1 on chromatin remodeling activities (17) and/or on the binding of linker histone H1 to chromatin (47). Thus, HMGN1 affects the position or stability of the
nucleosomes that are most susceptible to micrococcal nuclease
digestion, i.e., the nucleosomes located in CGI-containing promoters of transcriptionally active genes.
HMGN1 modulates the DNase I hypersensitivity in the CGI
promoters of ESCs. Changes in nucleosome occupancy may affect the locations and strengths of the DNase I-hypersensitive sites
(DHS) which are hallmarks of regulatory regions in chromatin. In
NPCs, we identified 30,199 DHS and found significant overlap
between the locations of DHS and HMGN1 (Fig. 6A and B). The
HMGN1-binding signal at HMGN1-DHS overlapping sites was
significantly stronger than that at nonoverlapping sites (P value ⬍
2.2e–16; Wilcoxon rank sum test) (bar graph, Fig. 6C, panels a and
b), and the HMGN1-DHS overlapping sites were preferentially
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FIG 6 Colocalization of HMGN1 and DNase I hypersensitivity sites (DHS) in neural progenitor cells. (A) Correlation between HMGN1 intensity and DNase I
hypersensitivity at all DHS. Average coverage depths (of HMGN1 or hypersensitivity) were calculated at all DNase I-hypersensitive regions. Data, including the
corresponding DNase I hypersensitivity data points, were sorted by HMGN coverage depth and then grouped into 100 data point bins and averaged. The Pearson
correlation coefficient (R) was calculated for the binned data. (B) Correlation between input signal and DNase hypersensitivity at the same regions. (C)
Distributions of HMGN1 peaks that either do or do not overlap DNase HS sites (top two panels) and DNase HS sites that either do or do not overlap HMGN1
peaks (bottom). Note that the overlapping regions have stronger signal intensities and are mostly located in gene promoters. (D) An example of colocalization
between HMGN1, DNase I hypersensitivity, and gene promoters.

located at promoters (pie chart, Fig. 6C, panels a and b). Thus,
66.5% of the HMGN1 peaks that overlap DHS but only 10.7% of
the HMGN1 sites that do not overlap DHS localize to promoters.
Likewise, DHS that overlap HMGN1 have significantly more intense peaks (P value ⬍ 2.2e–16; Wilcoxon rank sum test) and
localize to promoter regions with a 3-fold higher frequency
(65.4% versus 22.1%) than DHS that do not overlap HMGN1
(Fig. 6C panels c and d).
In Hmgn1⫹/⫹ ESCs, we identified 56,156 DHS; 67% of these
overlapped with the sites in CJ7 mouse ES cells mapped by the
Mouse Encode Project (see Fig. S5 in the supplemental material).
In Hmgn1⫺/⫺ ESCs, however, we identified only 17,017 sites; 12%
of the DHS are new and were not detected in Hmgn1⫹/⫹ ESC, and
88% (15,042) of the sites overlapped the sites detected in wild-type
ESCs (Fig. 7A). The DHS retained in Hmgn1⫺/⫺ ESCs were preferentially located in CGI promoters: 58% of the 15,022 DHS that
were located in the CGI promoters in Hmgn1⫹/⫹ ESCs were re-

tained in Hmgn1⫺/⫺ ESCs. In contrast, only 15% of 41,156 DHS
that were not in CGI promoters were retained. Importantly, the
intensity of the DHS retained in Hmgn1⫺/⫺ ESCs was significantly
lowered (t test P value ⬍ 2.2e–16) (Fig. 7B and H), especially at the
sites located in CGI promoters (Fig. 7C).Quantitative PCR analysis of the kinetics of DNase I digestion of 5 promoters verified that
loss of HMGN1 decreases the DNase I hypersensitivity of these
regions (Fig. 7G; see also Table S4 in the supplemental material).
The DNase I hypersensitivity of two (Actb and Gapdh) housekeeping gene promoters, which served as controls, was not affected by
loss of HMGN1. In NPC, we found that loss of HMGN1 reduced
the number of DHS from 30,199 to 23,320 (Fig. 7D). Within the
23,320 DHS identified in Hmgn1⫺/⫺ NPCs, 11% were new and
89% overlapped the sites present in Hmgn1⫹/⫹. Loss of HMGN1
did not significantly alter the DHS sensitivity of the retained, overlapping sites (Fig. 7E and F).
Thus, loss of HMGN1 affects the structure of the hyperdy-

FIG 5 Nucleosome positioning at gene transcription start sites (TSS) in ES and NP cells. (A) MNase digestions of ESCs and NPCs; the sizes of the isolated
monomers from limited and extensive digests are shown in the bottom panels. (B) Occupancy of nucleosome isolated from limited and extensive digests at the
TSS. (C and D) Nucleosome occupancy at TSS of Top40 and Bot40 (Bottom40) genes that either do or do not contain CpG islands after extensive digestion (C)
and limited digestion (D). (E and F) Correlation between nucleosome positioning at TSS and gene expression levels at ESCs (E) and NPCs (F). Genes were divided
into 8 groups based on expression values (log2) as shown at the top of panels E and F. (G and H) Effects of HMGN1 depletion on nucleosome occupancy in the
promoters of ESCs and NPCs. Arrows point to the position of the 0 nucleosome, located just upstream of the TSS.
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FIG 7 Reduced DNase I hypersensitivity in Hmgn1⫺/⫺ ES cells. (A) DHS in Hmgn1⫹/⫹ and Hmgn1⫺/⫺ ESCs. (B) Decreased DNase I in Hmgn1⫺/⫺ ESCs. Data

represent intensities measured at sites that overlap that are present in both Hmgn1⫹/⫹ and Hmgn1⫺/⫺ cells. (C) Loss of HMGN1 decreases the DNase I sensitivity
at CpG promoters of ESCs. (D) DHS in Hmgn1⫹/⫹ and Hmgn1⫺/⫺ NP cells. (E) HMGN1 does not affect the DHS in NP cells. (F) HMGN1 does not affect the
DHS at the CpG promoters in NP cells. (G) Quantitative PCR validation of DNase I-seq results in ES cells. The results determined with a control taken from a
region that is not digested by DNase I verify that equal amounts of DNA were loaded for Hmgn1⫹/⫹ and Hmgn1⫺/⫺ cells. (H) A genome browser view of DNase
I hypersensitivity of Hmgn1⫹/⫹ and Hmgn1⫺/⫺ ES cells.

namic chromatin of ESCs to a larger extent than that of the developmentally committed chromatin of NPC, a finding fully compatible with increased nucleosome occupancy seen in limited
micrococcal nuclease digests in ESCs. Loss of HMGN1 reduces the
DHS located in intergenic region and gene bodies to a larger extent than the sites located at CGI promoters, providing a partial
explanation for the moderate effects on transcription levels.
DISCUSSION

Our studies of ESC chromatin reveal that HMGN1, one of the
few nuclear proteins that bind specifically to nucleosome cores
but not to isolated histones or DNA, affects the organization of
nucleosomes and the DNase I hypersensitivity at active pro-
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moters containing CGI. Loss of HMGN1 has only slight effects
on the ESC cellular transcription profile and their potential to
differentiate into neuronal cells; however, in the brain of
Hmgn1⫺/⫺ mice, the levels of neural progenitors in the SVZ
region are reduced.
Nucleosome positioning around the TSS of active promoters plays a key role in gene expression. In limited micrococcal
nuclease digests, in which only 5% of the genome is converted
to nucleosome core particles (CPs), we detect a well-positioned
nucleosome at the TSS in a region considered to be nucleosome
depleted. The presence of this nucleosome is especially obvious
in the CGI promoters of transcriptionally active genes in ESCs
(Fig. 5D). The nucleosomes at the TSS of transcribed genes are
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likely to be relatively unstable (46) and most accessible to micrococcal nuclease; they are rapidly released and then further
digested, leading to nucleosome-free regions which are most
clearly delineated at TSS of genes containing CGI (25). Our
analysis of the limit digests reveals a correlation between transcription levels and nucleosome occupancy at the TSS. The
occupancy is highest in the most transcribed genes and lowest
in the least transcribed genes, suggesting that the nucleosomes
from the most transcriptionally active genes are the most rapidly released during digestion. However, once released, these
nucleosomes, which may contain H2Az variants, are unstable;
they are rapidly digested and, therefore, in the extensive micrococcal nuclease digests, the promoters of the most active genes
show the most prominent nucleosome-free region. Thus, our
studies reveal that the stability of nucleosomes at the TSS is
inversely related to transcription levels, since the nucleosomes
from the most active genes are most abundant in limit digests
and least abundant in extensive digests, while the nucleosomes
from the least transcribed genes are most abundant in extensive
digests and least abundant in limit digests (compare T1 to T8 in
Fig. 5E and F).
Loss of HMGN1, which preferentially binds to TSS containing
CGI (Fig. 4), stabilizes the position of the nucleosomes at these
TSS—an unexpected finding, since HMGN proteins stabilize the
structure of isolated nucleosomes (48) and loss of the protein
would therefore be expected to sensitize the released nucleosomes
to further digestion. Several mechanisms could account for the
effects of HMGN1 on nucleosome positioning and stability. First,
because HMGN1 competes with histone H1 (47), loss of HMGN1
would increase H1 binding, thereby decreasing the ability of micrococcal nuclease to access its initial digestion sites in the linker
DNA (8) and subsequently further degrade the released nucleosome (49). Second, because HMGN1 reduces the chromatin interaction of nucleosome remodeling complexes (17), loss of
HMGN1 could enhance the ability of these complexes to position
nucleosomes at the TSS. Third, HMGN1 can transiently enhance
the levels of histone acetylation and destabilize nucleosomes during transcription activation (50); therefore, its loss could enhance
the stability of a nucleosome at the TSS. Fourth, because HMGN1
is found in metastable multiprotein complexes (51) and interacts
with chromatin modifiers such as PCNA (52) and procyclic acidic
repetitive protein 1 (PARP1) (53), loss of HMGN1 could affect the
binding of these proteins to chromatin. Since nucleosome positioning is determined by the coordinated action of several factors,
including DNA-binding proteins (18), it remains to be seen
whether one or several of these factors are most specifically affected by HMGN1.
A possible link between the presence of HMGN and the generation of DHS in globin genes has been previously suggested (16);
however, the extent to which HMGN proteins shape regulatory
sites in chromatin is not known. We now find that in NPCs,
HMGN1 colocalizes extensively with DHS genome wide in a fashion similar to that seen in human T cells (20). In both NPCs and
human T cells, the hypersensitivity of the DHS that colocalize with
HMGN1 is stronger than that of the sites that do not colocalize
with HMGN1 (Fig. 6). Furthermore, in both NPCs and T cells, the
positional overlap of HMGN1 with DHS is especially striking in
the promoter region. In NPCs, 65% of the DHS that overlap
HMGN1 but only 22% of the sites that do not overlap are located
in the promoter region (Fig. 6C, panels c and d). Likewise, in the
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promoter region of human T cells, the frequency of DHS that
overlap HMGN1 is 3-fold higher than that of sites that do not
overlap HMGN1 (28% versus 10%) (20). The preference for
HMGN1 to colocalize with the DHS in promoters is even more
striking. In NPCs, 66% of the HMGN1 sites that overlap DHS but
only 11% of the sites that do not overlap DHS localize to promoter
regions. In T cells, the ratio is 32% versus 2% (20). These studies
raise the possibility that preferential colocalization of HMGN1
with DHS in promoter regions is a general characteristic of vertebrate chromatin.
Loss of HMGN1 leads to a significant reduction in DHS, especially in the hyperdynamic chromatin of ESCs, where the number
of sites is reduced from 56,156 in Hmgn1⫹/⫹ to 17,017 in
Hmgn1⫺/⫺ ESCs. The DHS retained in Hmgn1⫺/⫺ ESCs preferentially localize at promoters containing CGI, providing a partial
explanation for the relative small changes in transcription seen in
these cells. Loss of HMGN1 reduces not only the number but also
the hypersensitivity of the retained DHS (Fig. 7B), suggesting that
HMGN1 plays a role in maintaining their DNase I sensitivity.
Likewise, in NPCs, loss of HMGN1 reduces the number of DHS
(Fig. 7D), an expected finding given their extensive colocalization
and the observation that the presence of HMGN1 at a site affects
its DNase I sensitivity (Fig. 6). Similarly to ESCs, the retained sites
localize to CGI promoters; however, in contrast to ESCs, the
DNase I hypersensitivity at these sites is not markedly changed,
perhaps because their chromatin is less malleable.
Thus, loss of HMGN1 in ESCs affects two important aspects of
chromatin organization: nucleosome positioning at the TSS and
DNase I hypersensitivity. These effects are moderate, perhaps because HMGN1 functions within a dynamic framework of chromatin-binding proteins that compete for similar sites on nucleosomes. Thus, the absence of HMGN1 could facilitate the binding
of another HMGN variant, especially to sites with high affinity for
HMGN proteins, thereby minimizing changes in chromatin
structure and activity. Indeed, preliminary experiments suggest
that loss of HMGN1 induces reorganization in the chromatin
binding of the closely related variant HMGN2.
Given that HMGN1 is expressed in most vertebrate cells, binds
specifically to nucleosomes, localizes to DHS, and affects the binding of linker H1 to chromatin, its loss would be expected to have
significant effects on transcription and the cellular phenotype. Yet
our present experiments and analysis of MEFs from mice lacking
HMGN variants indicate that loss of a single HMGN has only
minor effects on the cellular transcription profile (21). As elaborated above, functional redundancy among HMGN variants and
other compensatory events in chromatin may minimize the deleterious effects of a lack of any specific variant, including HMGN1.
Yet several types of experiments, including analysis of Hmgn⫺/⫺
mice, reveal that lack of a single HMGN variant may lead to specific phenotypes. Thus, Hmgn3⫺/⫺ mice are diabetic (54) and
Hmgn1⫺/⫺ mice are hypersensitive to DNA damage and have an
increased incidence of certain cancers (29, 55). The emerging data
suggest that each HMGN variant contributes to the maintenance
of the fidelity of the cellular transcription profile and that loss of a
variant is deleterious, especially under stress condition such as
exposure to heat shock (50) or DNA-damaging agents (29, 53, 55).
Indeed, we now find that even though the Hmgn1⫺/⫺ ESCs seem
to grow and differentiate normally, they are hypersensitive to the
DNA-damaging agent doxorubicin (Adriamycin) (see Fig. S6 in
the supplemental material). Likewise, the decrease in nestin-pos-
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itive cell numbers in the SVZ region of Hmgn1⫺/⫺ mice suggests
that while the Hmgn1⫺/⫺ ESCs are not visibly affected in tissue
culture, in the context of the entire organism, loss of HMGN1
impedes the differentiation or the survival of NP cells. Loss of
HMGN1 also alters the behavior of mice, most likely by changing
expression of MeCp2, a protein that is highly expressed in neurons
(37). Our studies link these phenotypic changes to HMGN1-mediated alterations in chromatin structure.
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